GSK plc

GSK plc

World Rank (Aug-2026)
243
Market Cap (Aug-2026)
100.284 Billion USD
World Rank (Jan-05-2024)
179
Market Cap (Jan-05-2024)
80.265 Billion USD
World Rank (Jul-30-2023)
212
Market Cap (Jul-30-2023)
72.563 Billion USD
World Rank (Jan-07-2022)
132
Market Cap (Jan-07-2022)
110.320 Billion USD
World Rank (Jan-01-2021)
146
Market Cap (Jan-01-2021)
91.765 Billion USD
Company Rank in Country in 2023
Company rank in UK in July-2023 is 9
Headquarters Country
UK
Top Healthcare Companies in UK
Top Technology Companies in UK
Top Healthcare Companies in Europe
Top Technology Companies in Europe
Top Pharmaceutical Companies in Europe
Nasdaq / NYSE Code
GSK
CEO
Dame Emma Walmsley
Chairman
Jonathan Symonds
Employee Count
70,000
Employee Count as of Date
As on 2022
Headquarters City/State
London
World Region
Europe
World Subregion
Northern Europe
Annual Revenue in USD
44,729 Million USD
Annual Operating Income in USD
11,417 Million USD
Annual Net Income in USD
7,827 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
83,686 Million USD
Total Liabilities in USD
61,838 Million USD
Total Equity in USD
21,848 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Biotechnology
Technology
Company Website
GSK - Pharmaceutical and Healthcare Company
Wikipedia
Wikipedia
Yahoo
Yahoo @ NYSE
Facebook
Facebook
Company Profile

GLAXOSMITHKLINE is UK based multi-national Pharmaceuticals business and it has a broad portfolio of innovative and established medicines. GSK currently focus on developing new medicines in respiratory, HIV, oncology and immuno-inflammation; with an R&D approach focused on science related to the immune system, use of genetics and advanced technologies. Headquarters is in UK.

In 2021 GSK delivered 1.7 billion medicines, over 767 million vaccines* and 3.7 billion consumer healthcare products.

Facts About Company

GSK annual revenue was 29,324 Million GBP and annual net income was 14,956 Million GBP for year ending Dec-2022.

GSK annual revenues for year ending Dec-2021 was 34,144 million GBP and annual operating income was 6,165 million GBP and annual net income of 4,385 million GBP.

GSK had 70,000 employees as on 2022.

As on 2021, GSK has over 90,000 employees across 92 countries and work directly with 37,500 suppliers.

Annual Results Summary

GLAXOSMITHKLINE - Annual Results - Revenue and Net Profit - in Million GBP:

YearTotal Annual Revenue (GBP million)Gross Profit (GBP million)Operating Profit (GBP million)Net Income (GBP million)
202532,66723,6507,9325,716
202431,37622,3284,0212,575
202330,32821,7636,7454,928
202229,32419,7706,43314,956
202134,11422,5116,2014,385
202034,09922,3957,7835,749
201933,75421,8916,9614,645
201830,82120,5805,4833,623
201730,18619,8444,0871,532
201627,88918,5992,598912


 

Balance Sheet Summary

GLAXOSMITHKLINE - Balance Sheet Summary - in Million GBP:

YearTotal Assets (GBP million)Total Liabilities (GBP million)Total Equity (GBP million)
202561,11845,16215,956
202459,46346,37713,086
202359,00546,21012,795
202260,14650,05010,096
202179,10357,76121,342
202080,43159,62320,808
201979,69261,33518,357
201858,06654,3943,672
201756,38152,8923,489
201659,08154,1184,963
Founded Year
2000
IPO Year
2022
ISIN Code
GB0009252882
Stock Category
FTSE 100
S&P EUROPE 350
UK ADRs
Stock Exchange
NYSE
Frankfurt
LSE
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share